Other
Indirect Pulp Cap
0
Pipeline Programs↗
1
Active Trials↗
0
Companies Involved↗
Indirect Pulp Cap is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
6
clinical trials
Unknown status3 · 50%
Completed2 · 33%
Recruiting1 · 17%
Clinical Trials
Trial Activity
6 trials
Comparison Between Egyptian MTA, Biodentine Versus Calcium Hydroxide as Indirect Pulp Capping Materials In Permanent Teeth
Recruiting·—·Phase 4·NCT06683833·35 enrolled
Clinical and Radiographic Evaluation of Indirect Pulp Capping in Primary and Permanent Teeth With Different Materials
Completed·—·N/A·NCT03606681·300 enrolled
Clinical And Radiographic Evaluation Of Premixed Bio-ceramic MTA In Indirect Pulp Capping Of Young Permanent Molars
Unknown status·—·Phase 3·NCT05928858·40 enrolled
Comparing Two Indirect Pulp Capping Agents for Permanent Teeth
Unknown status·—·N/A·NCT05425368·30 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)